Coinfection Between Amoebic Liver Abscess Caused By Entamobea histolytica And Hepatitis A in AL-Najaf Governorate
DOI:
https://doi.org/10.46966/msjar.v5i1.187Keywords:
Amoebic Liver Abscess, Hepatitis A, Hematological Parameters, Entamoebae Histolytica, IL-2,8,10Abstract
Background: It was the goal of the current research study to determine the link between hepatitis a virus infection and amoebic liver abscess, as well as to determine the effects of hepatitis a viruses and amoebic liver abscess on the serum levels of biochemical markers such as IL-2, IL-8, and IL-10 (ALP, ALT, AST and TSB) From February 2021 to January 2022, the current study was conducted. Patients from Al Furat General Hospital in AL-Najaf Province, Al Sader General Hospital, AL-Zahra maternity and pediatrics, and AL-Hakeem Hospital have been referred to this laboratory for testing. Hepatitis A infection and amoebic liver abscess coinfection were both more common in men than in women, according to the findings of the current study. Hepatitis A was found to be most prevalent in males between the ages of 8 and 17 and females between the ages of 18 and 27 in the current investigation. Results from the current study show that interleukin 2 concentrations rose in coinfections between amoebic liver abscess and Hepatitis A at a rate of (13.572-8341.2) compared to Hepatitis A (11.113-873.4) and Amoebic liver abscess (8.789-473.2). However, interleukin 8 concentrations rose to the highest level in Amoebic liver abscess (12.32-555.43) compared to Hepatitis A (5.765-64.5). (35-322.8), Coinfection between amoebic liver abscess and Hepatitis A was shown to have the highest level of ALT (9.19-812.2) compared to Hepatitis A (23.8-102.6) and Amoebic liver abscess (32.12-50.1) ,(0.12-3.32).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 ijdan Dhaidan Shnain Al-Abbas, Eman Hamza Mohammed, Nadia Habeeb Sarhan
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
